Sabby Management, LLC Sorrento Therapeutics, Inc. Transaction History

Sabby Management, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$2.0 - $4.9 $4.38 Million - $10.7 Million	-2,189,700 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$4.65 - $7.23 $2.29 Million - $3.55 Million	491,593 Added 28.95%	2,189,700 $10.2 Million
Q3 2021 Nov 15, 2021	BUY	$7.41 - $10.99 $3.71 Million - $5.5 Million	500,131 Added 41.75%	1,698,107 $13 Million
Q2 2021 Aug 16, 2021	BUY	$6.35 - $10.0 $844,823 - $1.33 Million	133,043 Added 12.49%	1,197,976 $11.6 Million
Q1 2021 May 17, 2021	BUY	$7.03 - $16.51 $7.49 Million - $17.6 Million	1,064,933 New	1,064,933 $8.81 Million
Q4 2020 Feb 16, 2021	SELL	$5.76 - $11.95 $3.49 Million - $7.25 Million	-606,298 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$6.17 - $18.82 $3.74 Million - $11.4 Million	606,298 New	606,298 $6.76 Million
Q2 2020 Aug 14, 2020	SELL	$1.73 - $6.76 $497,177 - $1.94 Million	-287,386 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$1.57 - $4.76 $408,526 - $1.24 Million	260,208 Added 957.42%	287,386 $529,000
Q4 2019 Feb 14, 2020	BUY	$1.45 - $4.17 $39,408 - $113,332	27,178 New	27,178 $92,000
Q1 2019 May 15, 2019	SELL	$1.86 - $5.94 $157,236 - $502,143	-84,536 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$2.01 - $4.24 $169,917 - $358,432	84,536 New	84,536 $0

5.47M

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

Get notified when there are updates to the investment portfolio of Sabby Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sabby Management, LLC with notifications on news.